Case Management for Crack Users Who Seek Treatment in CAPSad in Brazil

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Federal University of Rio Grande do Sul.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Hospital de Clinicas de Porto Alegre
Brazilian Secretariat for Drug Policies (SENAD)
Federal University of Bahia
Federal University of Espirito Santo
Universidade Federal do Rio de Janeiro
Faculdade de Medicina do ABC
University of Brasilia
Information provided by (Responsible Party):
Professor Flavio Pechansky, Federal University of Rio Grande do Sul
ClinicalTrials.gov Identifier:
NCT01558726
First received: March 17, 2012
Last updated: NA
Last verified: March 2012
History: No changes posted
  Purpose

The purpose of this study is to evaluate the effectiveness of a Case Management (CM) intervention in crack users applied in Psychosocial Care Centers - Alcohol and Drugs (CAPSad) by trained social workers, in comparison to CAPSad conventional treatment on 30 and 90 days, considering the following outcomes: treatment retention, abstinence and changes in severity scores of the sixth version of Addiction Severity Index (ASI6) scale. The study hypothesis are: 1) The CM is going to improve the retention of crack users (cases) during the 3-month follow-up compared with usual care (controls); 2)Individuals who received the intervention with GC are going to present a higher rate of abstinence; 3)The summary scores of the ASI6 will be significantly lower in cases than in controls, at the end of 3 months follow-up.


Condition Intervention
Crack Abuse or Dependence
Behavioral: Case Management (Strength-Based)
Behavioral: Usual Treatment

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: Effectiveness of Case Management for Crack Users Who Seek Treatment in CAPSad in Six Brazilian Capitals

Further study details as provided by Federal University of Rio Grande do Sul:

Primary Outcome Measures:
  • Treatment retention [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Crack abstinence [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • ASI subareas scores [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    ASI (Addiction Severity Index)


Estimated Enrollment: 600
Study Start Date: October 2011
Estimated Study Completion Date: August 2012
Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Case management Behavioral: Case Management (Strength-Based)
To improve the cases sharing between CAPSad and other health institutions and individuals and increase the strengths of the patient to cope with problems related to the crack use.
Active Comparator: Usual treatment
Usual treatment of the CAPSad
Behavioral: Usual Treatment
The usual treatment used for regular patients of CAPSad

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of crack abuse or dependence
  • > 18 years old
  • Initiating treatment (maximum of 1 month)

Exclusion Criteria:

  • Homeless without permanent contact
  • Psychotic symptoms during the intake interview
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01558726

Contacts
Contact: Flavio Pechansky, PhD 55-51-3359-7480 fpechans@uol.com.br
Contact: Felix HP Kessler, PhD

Locations
Brazil
Center for Drug and Alcohol Research (CPAD) of Federal University of Rio Grande do Sul (UFRGS) Recruiting
Porto Alegre, Rio Grande do Sul, Brazil, 90035-903
Contact: Flavio Pechansky, PhD    55-51-3359-7480    fpechans@uol.com.br   
Contact: Felix HP Kessler, PhD    55-51-3359-7480    kessler.ez@terra.com.br   
Principal Investigator: Flavio Pechansky, PhD         
Sub-Investigator: Felix HP Kessler, PhD         
Sub-Investigator: Sibele Faller, Ms         
Sponsors and Collaborators
Federal University of Rio Grande do Sul
Hospital de Clinicas de Porto Alegre
Brazilian Secretariat for Drug Policies (SENAD)
Federal University of Bahia
Federal University of Espirito Santo
Universidade Federal do Rio de Janeiro
Faculdade de Medicina do ABC
University of Brasilia
Investigators
Principal Investigator: Flavio Pechansky, PhD Center for Drug and Alcohol Research (CPAD) of Federal University of Rio Grande do Sul
  More Information

No publications provided

Responsible Party: Professor Flavio Pechansky, Director of Center for Drug and Alcohol Research (CPAD-UFRGS), Federal University of Rio Grande do Sul
ClinicalTrials.gov Identifier: NCT01558726     History of Changes
Other Study ID Numbers: 10-0176
Study First Received: March 17, 2012
Last Updated: March 17, 2012
Health Authority: Brazil: National Health Surveillance Agency

Keywords provided by Federal University of Rio Grande do Sul:
Case Management
Crack abuse/dependents
Evaluation
Inpatient
ASI
Treatment retention
Abstinence

ClinicalTrials.gov processed this record on September 11, 2014